| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | intracellularly cAMP-activated cation channel activity | 2.75e-06 | 10 | 58 | 3 | GO:0005222 | |
| GeneOntologyMolecularFunction | intracellularly cyclic nucleotide-activated monoatomic cation channel activity | 6.52e-06 | 13 | 58 | 3 | GO:0005221 | |
| GeneOntologyMolecularFunction | cyclic nucleotide-activated monoatomic ion channel activity | 6.52e-06 | 13 | 58 | 3 | GO:0043855 | |
| GeneOntologyMolecularFunction | cAMP binding | 5.11e-05 | 25 | 58 | 3 | GO:0030552 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 5.77e-05 | 26 | 58 | 3 | GO:0005248 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 1.19e-04 | 33 | 58 | 3 | GO:0005217 | |
| GeneOntologyMolecularFunction | cyclic nucleotide binding | 1.97e-04 | 39 | 58 | 3 | GO:0030551 | |
| GeneOntologyMolecularFunction | sodium channel activity | 4.65e-04 | 52 | 58 | 3 | GO:0005272 | |
| GeneOntologyMolecularFunction | GTPase binding | 6.05e-04 | 360 | 58 | 6 | GO:0051020 | |
| GeneOntologyMolecularFunction | magnesium ion binding | 7.47e-04 | 247 | 58 | 5 | GO:0000287 | |
| GeneOntologyMolecularFunction | small GTPase binding | 2.38e-03 | 321 | 58 | 5 | GO:0031267 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 2.43e-03 | 194 | 58 | 4 | GO:0016705 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 2.99e-03 | 28 | 58 | 2 | GO:0051959 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | TUBB1 BICD2 CDC42BPA DNAH17 SYNE2 CUL9 TUBB2B DIAPH3 CUL7 TUBB2A | 2.89e-05 | 720 | 58 | 10 | GO:0000226 |
| GeneOntologyBiologicalProcess | microtubule-based process | TUBB1 BICD2 CDC42BPA KIF1A DNAH17 SYNE2 CUL9 TUBB2B DIAPH3 CUL7 ADCY3 TUBB2A | 3.11e-05 | 1058 | 58 | 12 | GO:0007017 |
| GeneOntologyCellularComponent | HCN channel complex | 8.09e-08 | 4 | 58 | 3 | GO:0098855 | |
| GeneOntologyCellularComponent | intercellular bridge | 1.35e-04 | 94 | 58 | 4 | GO:0045171 | |
| GeneOntologyCellularComponent | cell body | 2.14e-04 | 929 | 58 | 10 | GO:0044297 | |
| GeneOntologyCellularComponent | neuronal cell body | 4.55e-04 | 835 | 58 | 9 | GO:0043025 | |
| GeneOntologyCellularComponent | somatodendritic compartment | BPTF BMPR2 NF1 KIF1A HCN4 HCN1 CYP19A1 SERPINF1 HCN2 STAR HDC | 4.88e-04 | 1228 | 58 | 11 | GO:0036477 |
| GeneOntologyCellularComponent | dendrite | 5.54e-04 | 858 | 58 | 9 | GO:0030425 | |
| GeneOntologyCellularComponent | dendritic tree | 5.64e-04 | 860 | 58 | 9 | GO:0097447 | |
| Domain | Ion_trans_N | 1.02e-07 | 4 | 56 | 3 | PF08412 | |
| Domain | Ion_trans_N | 1.02e-07 | 4 | 56 | 3 | IPR013621 | |
| Domain | Beta-tubulin_BS | 3.02e-06 | 10 | 56 | 3 | IPR013838 | |
| Domain | Beta_tubulin | 3.02e-06 | 10 | 56 | 3 | IPR002453 | |
| Domain | TUBULIN_B_AUTOREG | 4.14e-06 | 11 | 56 | 3 | PS00228 | |
| Domain | K_chnl_volt-dep_EAG/ELK/ERG | 9.08e-06 | 14 | 56 | 3 | IPR003938 | |
| Domain | cNMP-bd_CS | 1.39e-05 | 16 | 56 | 3 | IPR018488 | |
| Domain | Cul7 | 2.64e-05 | 3 | 56 | 2 | PF11515 | |
| Domain | CPH_domain | 2.64e-05 | 3 | 56 | 2 | IPR021097 | |
| Domain | - | 2.81e-05 | 20 | 56 | 3 | 3.30.1330.20 | |
| Domain | - | 3.27e-05 | 21 | 56 | 3 | 1.10.287.600 | |
| Domain | Tubulin_C | 3.78e-05 | 22 | 56 | 3 | SM00865 | |
| Domain | Tubulin_C | 3.78e-05 | 22 | 56 | 3 | PF03953 | |
| Domain | Tubulin/FtsZ_2-layer-sand-dom | 3.78e-05 | 22 | 56 | 3 | IPR018316 | |
| Domain | - | 3.78e-05 | 22 | 56 | 3 | 3.40.50.1440 | |
| Domain | Tubulin_C | 4.33e-05 | 23 | 56 | 3 | IPR023123 | |
| Domain | TUBULIN | 4.33e-05 | 23 | 56 | 3 | PS00227 | |
| Domain | Tubulin | 4.33e-05 | 23 | 56 | 3 | IPR000217 | |
| Domain | Tub_FtsZ_C | 4.33e-05 | 23 | 56 | 3 | IPR008280 | |
| Domain | Tubulin | 4.33e-05 | 23 | 56 | 3 | SM00864 | |
| Domain | Tubulin_CS | 4.33e-05 | 23 | 56 | 3 | IPR017975 | |
| Domain | Tubulin_FtsZ_GTPase | 4.94e-05 | 24 | 56 | 3 | IPR003008 | |
| Domain | Tubulin | 4.94e-05 | 24 | 56 | 3 | PF00091 | |
| Domain | CNMP_BINDING_1 | 1.19e-04 | 32 | 56 | 3 | PS00888 | |
| Domain | CNMP_BINDING_2 | 1.19e-04 | 32 | 56 | 3 | PS00889 | |
| Domain | cNMP | 1.43e-04 | 34 | 56 | 3 | SM00100 | |
| Domain | cNMP_binding | 1.43e-04 | 34 | 56 | 3 | PF00027 | |
| Domain | cNMP-bd_dom | 1.56e-04 | 35 | 56 | 3 | IPR000595 | |
| Domain | CNMP_BINDING_3 | 1.56e-04 | 35 | 56 | 3 | PS50042 | |
| Domain | APC_su10/DOC_dom | 1.84e-04 | 7 | 56 | 2 | IPR004939 | |
| Domain | DOC | 1.84e-04 | 7 | 56 | 2 | PS51284 | |
| Domain | APC10 | 1.84e-04 | 7 | 56 | 2 | SM01337 | |
| Domain | ANAPC10 | 1.84e-04 | 7 | 56 | 2 | PF03256 | |
| Domain | cNMP-bd-like | 2.00e-04 | 38 | 56 | 3 | IPR018490 | |
| Domain | Cullin_Nedd8 | 2.44e-04 | 8 | 56 | 2 | PF10557 | |
| Domain | Cullin_Nedd8 | 2.44e-04 | 8 | 56 | 2 | SM00884 | |
| Domain | Cullin_neddylation_domain | 2.44e-04 | 8 | 56 | 2 | IPR019559 | |
| Domain | Cullin_homology | 3.14e-04 | 9 | 56 | 2 | IPR016158 | |
| Domain | Cullin | 3.91e-04 | 10 | 56 | 2 | PF00888 | |
| Domain | CULLIN_2 | 3.91e-04 | 10 | 56 | 2 | PS50069 | |
| Domain | Cullin_N | 3.91e-04 | 10 | 56 | 2 | IPR001373 | |
| Domain | CULLIN_1 | 3.91e-04 | 10 | 56 | 2 | PS01256 | |
| Domain | - | 4.01e-04 | 48 | 56 | 3 | 2.60.120.10 | |
| Domain | RmlC-like_jellyroll | 4.80e-04 | 51 | 56 | 3 | IPR014710 | |
| Domain | CH | 9.78e-04 | 65 | 56 | 3 | SM00033 | |
| Domain | CH | 1.21e-03 | 70 | 56 | 3 | PF00307 | |
| Domain | - | 1.26e-03 | 71 | 56 | 3 | 1.10.418.10 | |
| Domain | Rib_L2_dom2 | 1.31e-03 | 18 | 56 | 2 | IPR014722 | |
| Domain | - | 1.31e-03 | 18 | 56 | 2 | 2.30.30.30 | |
| Domain | CH | 1.37e-03 | 73 | 56 | 3 | PS50021 | |
| Domain | CH-domain | 1.48e-03 | 75 | 56 | 3 | IPR001715 | |
| Domain | ARM-type_fold | 3.42e-03 | 339 | 56 | 5 | IPR016024 | |
| Domain | - | 4.40e-03 | 222 | 56 | 4 | 1.25.10.10 | |
| Domain | Ion_trans_dom | 4.85e-03 | 114 | 56 | 3 | IPR005821 | |
| Domain | Ion_trans | 4.85e-03 | 114 | 56 | 3 | PF00520 | |
| Pathway | REACTOME_SIGNALING_BY_HEDGEHOG | 2.97e-06 | 137 | 42 | 6 | MM15182 | |
| Pathway | REACTOME_SIGNALING_BY_HEDGEHOG | 5.02e-06 | 150 | 42 | 6 | M27440 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 7.72e-06 | 43 | 42 | 4 | M47669 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | 9.28e-06 | 45 | 42 | 4 | M47670 | |
| Pathway | REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 1.20e-05 | 48 | 42 | 4 | MM15353 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_ESPG_TO_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 1.62e-05 | 17 | 42 | 3 | M47768 | |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 1.62e-05 | 17 | 42 | 3 | MM14731 | |
| Pathway | REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 1.79e-05 | 53 | 42 | 4 | M27651 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_DCTN1_TO_RETROGRADE_AXONAL_TRANSPORT | 1.95e-05 | 18 | 42 | 3 | M47753 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_IRON_TO_ANTEROGRADE_AXONAL_TRANSPORT | 2.31e-05 | 19 | 42 | 3 | M47818 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_ZN_TO_ANTEROGRADE_AXONAL_TRANSPORT | 2.31e-05 | 19 | 42 | 3 | M47813 | |
| Pathway | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | 2.31e-05 | 116 | 42 | 5 | MM15715 | |
| Pathway | REACTOME_KINESINS | 2.40e-05 | 57 | 42 | 4 | MM15714 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_MICROTUBULE_ATTACHMENT | 2.71e-05 | 20 | 42 | 3 | M47890 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION_AT_THE_MINUS_ENDS | 2.71e-05 | 20 | 42 | 3 | M47911 | |
| Pathway | REACTOME_KINESINS | 3.14e-05 | 61 | 42 | 4 | M977 | |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 3.15e-05 | 21 | 42 | 3 | M27067 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 3.15e-05 | 21 | 42 | 3 | M47767 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PROMOTION_OF_MICROTUBULE_GROWTH | 3.64e-05 | 22 | 42 | 3 | M47903 | |
| Pathway | REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT | 4.14e-05 | 131 | 42 | 5 | MM15497 | |
| Pathway | REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY | 4.18e-05 | 23 | 42 | 3 | M19135 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION | 4.18e-05 | 23 | 42 | 3 | M47910 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_FIBER_ORGANIZATION | 4.18e-05 | 23 | 42 | 3 | M47900 | |
| Pathway | REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT | 4.62e-05 | 134 | 42 | 5 | M27751 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANTEROGRADE_AXONAL_TRANSPORT | 4.77e-05 | 24 | 42 | 3 | M47671 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 4.77e-05 | 24 | 42 | 3 | M47700 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_SIFA_TO_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT | 5.40e-05 | 25 | 42 | 3 | M47775 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 5.40e-05 | 25 | 42 | 3 | M47710 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_ANTEROGRADE_AXONAL_TRANSPORT | 6.10e-05 | 26 | 42 | 3 | M47672 | |
| Pathway | REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC | 6.10e-05 | 26 | 42 | 3 | M9648 | |
| Pathway | REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN | 6.84e-05 | 27 | 42 | 3 | MM15549 | |
| Pathway | REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III | 6.84e-05 | 27 | 42 | 3 | MM15674 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_NUCLEATION | 7.65e-05 | 28 | 42 | 3 | M47898 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 8.51e-05 | 29 | 42 | 3 | MM15219 | |
| Pathway | REACTOME_ACTIVATION_OF_AMPK_DOWNSTREAM_OF_NMDARS | 8.51e-05 | 29 | 42 | 3 | M27948 | |
| Pathway | REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III | 1.15e-04 | 32 | 42 | 3 | M29848 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 1.15e-04 | 32 | 42 | 3 | M27491 | |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 1.15e-04 | 32 | 42 | 3 | MM14730 | |
| Pathway | REACTOME_COOPERATION_OF_PREFOLDIN_AND_TRIC_CCT_IN_ACTIN_AND_TUBULIN_FOLDING | 1.26e-04 | 33 | 42 | 3 | M27297 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BRANCHING_MICROTUBULE_NUCLEATION | 1.26e-04 | 33 | 42 | 3 | M47901 | |
| Pathway | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | 1.43e-04 | 170 | 42 | 5 | M941 | |
| Pathway | KEGG_GAP_JUNCTION | 1.44e-04 | 90 | 42 | 4 | M4013 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ARL8_REGULATED_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT | 1.51e-04 | 35 | 42 | 3 | M47774 | |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | 1.63e-04 | 175 | 42 | 5 | MM15599 | |
| Pathway | REACTOME_AGGREPHAGY | 1.64e-04 | 36 | 42 | 3 | MM15669 | |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 1.78e-04 | 37 | 42 | 3 | MM15102 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | 1.90e-04 | 411 | 42 | 7 | M735 | |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 1.93e-04 | 38 | 42 | 3 | M14981 | |
| Pathway | REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 2.01e-04 | 98 | 42 | 4 | MM15352 | |
| Pathway | REACTOME_PROTEIN_FOLDING | 2.01e-04 | 98 | 42 | 4 | M776 | |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | 2.06e-04 | 184 | 42 | 5 | M41809 | |
| Pathway | REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 2.17e-04 | 100 | 42 | 4 | M27650 | |
| Pathway | REACTOME_INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC | 2.34e-04 | 189 | 42 | 5 | MM15356 | |
| Pathway | REACTOME_HEDGEHOG_OFF_STATE | 2.62e-04 | 105 | 42 | 4 | MM15206 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RAB7_REGULATED_MICROTUBULE_MINUS_END_DIRECTED_TRANSPORT | 2.79e-04 | 43 | 42 | 3 | M47773 | |
| Pathway | REACTOME_AGGREPHAGY | 2.99e-04 | 44 | 42 | 3 | M29830 | |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 2.99e-04 | 44 | 42 | 3 | MM14606 | |
| Pathway | REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS | 2.99e-04 | 44 | 42 | 3 | M27934 | |
| Pathway | REACTOME_INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC | 3.25e-04 | 203 | 42 | 5 | M27654 | |
| Pathway | REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN | 3.41e-04 | 46 | 42 | 3 | M27828 | |
| Pathway | REACTOME_HEDGEHOG_OFF_STATE | 3.46e-04 | 113 | 42 | 4 | M27471 | |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 4.12e-04 | 49 | 42 | 3 | M891 | |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 4.64e-04 | 51 | 42 | 3 | M26972 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 4.91e-04 | 52 | 42 | 3 | MM14949 | |
| Pathway | REACTOME_INTRAFLAGELLAR_TRANSPORT | 4.91e-04 | 52 | 42 | 3 | MM15211 | |
| Pathway | REACTOME_INTRAFLAGELLAR_TRANSPORT | 5.49e-04 | 54 | 42 | 3 | M27482 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | 5.68e-04 | 649 | 42 | 8 | MM15690 | |
| Pathway | WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 5.79e-04 | 55 | 42 | 3 | M39613 | |
| Pathway | KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 6.11e-04 | 56 | 42 | 3 | M2333 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 6.43e-04 | 57 | 42 | 3 | M27251 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 7.78e-04 | 140 | 42 | 4 | M27550 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 7.99e-04 | 141 | 42 | 4 | MM15266 | |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | 9.88e-04 | 66 | 42 | 3 | MM17074 | |
| Pathway | WP_CLASSICAL_PATHWAY_OF_STEROIDOGENESIS_WITH_GLUCOCORTICOID_AND_MINERALOCORTICOID_METABOLISM | 1.01e-03 | 16 | 42 | 2 | M39815 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY | 1.08e-03 | 68 | 42 | 3 | MM14921 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 1.08e-03 | 68 | 42 | 3 | MM14968 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | 1.12e-03 | 720 | 42 | 8 | M41838 | |
| Pathway | WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY | 1.22e-03 | 71 | 42 | 3 | M39690 | |
| Pathway | REACTOME_RHOG_GTPASE_CYCLE | 1.22e-03 | 71 | 42 | 3 | MM15604 | |
| Pathway | REACTOME_TRANSLOCATION_OF_SLC2A4_GLUT4_TO_THE_PLASMA_MEMBRANE | 1.27e-03 | 72 | 42 | 3 | M26954 | |
| Pathway | WP_GENES_TARGETED_BY_MIRNAS_IN_ADIPOCYTES | 1.29e-03 | 18 | 42 | 2 | M39405 | |
| Pathway | WP_TRANSCRIPTION_COFACTORS_SKI_AND_SKIL_PROTEIN_PARTNERS | 1.29e-03 | 18 | 42 | 2 | M39825 | |
| Pathway | REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT | 1.32e-03 | 73 | 42 | 3 | MM15491 | |
| Pathway | REACTOME_SELECTIVE_AUTOPHAGY | 1.32e-03 | 73 | 42 | 3 | MM15672 | |
| Pathway | REACTOME_HEMOSTASIS | 1.35e-03 | 571 | 42 | 7 | MM14472 | |
| Pathway | REACTOME_RHOG_GTPASE_CYCLE | 1.38e-03 | 74 | 42 | 3 | M41814 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY | 1.49e-03 | 76 | 42 | 3 | M27215 | |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | 1.49e-03 | 76 | 42 | 3 | M48037 | |
| Pathway | REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT | 1.66e-03 | 79 | 42 | 3 | M27743 | |
| Pathway | BIOCARTA_RAC1_PATHWAY | 1.76e-03 | 21 | 42 | 2 | MM1463 | |
| Pathway | BIOCARTA_RAC1_PATHWAY | 1.76e-03 | 21 | 42 | 2 | M8601 | |
| Pathway | REACTOME_RAC2_GTPASE_CYCLE | 2.19e-03 | 87 | 42 | 3 | MM15600 | |
| Pathway | REACTOME_RAC2_GTPASE_CYCLE | 2.26e-03 | 88 | 42 | 3 | M41810 | |
| Pathway | REACTOME_SELECTIVE_AUTOPHAGY | 2.41e-03 | 90 | 42 | 3 | M29841 | |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | 2.41e-03 | 90 | 42 | 3 | MM14979 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 2.73e-03 | 94 | 42 | 3 | M2843 | |
| Pathway | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | 2.73e-03 | 94 | 42 | 3 | MM14515 | |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | 2.81e-03 | 95 | 42 | 3 | M6729 | |
| Pathway | REACTOME_CILIUM_ASSEMBLY | 2.94e-03 | 201 | 42 | 4 | M27472 | |
| Pathway | REACTOME_POTASSIUM_CHANNELS | 3.07e-03 | 98 | 42 | 3 | MM14545 | |
| Pubmed | 4.40e-09 | 3 | 58 | 3 | 33181864 | ||
| Pubmed | Ventricular HCN channels decrease the repolarization reserve in the hypertrophic heart. | 4.40e-09 | 3 | 58 | 3 | 22652004 | |
| Pubmed | 4.40e-09 | 3 | 58 | 3 | 21187420 | ||
| Pubmed | 4.40e-09 | 3 | 58 | 3 | 21945247 | ||
| Pubmed | 4.40e-09 | 3 | 58 | 3 | 22006928 | ||
| Pubmed | 9.37e-09 | 15 | 58 | 4 | 21147989 | ||
| Pubmed | 1.76e-08 | 4 | 58 | 3 | 16043489 | ||
| Pubmed | 1.76e-08 | 4 | 58 | 3 | 9405696 | ||
| Pubmed | 1.76e-08 | 4 | 58 | 3 | 12928435 | ||
| Pubmed | 1.76e-08 | 4 | 58 | 3 | 21615589 | ||
| Pubmed | 1.76e-08 | 4 | 58 | 3 | 20140458 | ||
| Pubmed | 1.76e-08 | 4 | 58 | 3 | 22748890 | ||
| Pubmed | Identification of a gene encoding a hyperpolarization-activated pacemaker channel of brain. | 1.76e-08 | 4 | 58 | 3 | 9630217 | |
| Pubmed | BICD2 SF3B1 KIF1A RALBP1 HCN1 YLPM1 USP32 UBQLN4 CUL9 MAGI3 TUBB2B WRAP53 SMURF2 TUBB2A | 1.82e-08 | 1285 | 58 | 14 | 35914814 | |
| Pubmed | Regulation of HCN channel surface expression by a novel C-terminal protein-protein interaction. | 4.39e-08 | 5 | 58 | 3 | 15564593 | |
| Pubmed | 4.39e-08 | 5 | 58 | 3 | 34429357 | ||
| Pubmed | 8.77e-08 | 6 | 58 | 3 | 25761792 | ||
| Pubmed | Transcription profiling of HCN-channel isotypes throughout mouse cardiac development. | 1.53e-07 | 7 | 58 | 3 | 19421833 | |
| Pubmed | Mutations in the β-tubulin gene TUBB5 cause microcephaly with structural brain abnormalities. | 2.45e-07 | 8 | 58 | 3 | 23246003 | |
| Pubmed | 5.24e-07 | 10 | 58 | 3 | 16382102 | ||
| Pubmed | Postnatal refinement of auditory hair cell planar polarity deficits occurs in the absence of Vangl2. | 5.24e-07 | 10 | 58 | 3 | 23986237 | |
| Pubmed | Arrhythmia induced by spatiotemporal overexpression of calreticulin in the heart. | 9.58e-07 | 12 | 58 | 3 | 17482496 | |
| Pubmed | 1.10e-06 | 322 | 58 | 7 | 26514267 | ||
| Pubmed | Pacsin 2 is required for the maintenance of a normal cardiac function in the developing mouse heart. | 1.58e-06 | 14 | 58 | 3 | 29107716 | |
| Pubmed | MEKK4 Signaling Regulates Sensory Cell Development and Function in the Mouse Inner Ear. | 2.43e-06 | 16 | 58 | 3 | 26818521 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 16806719 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 19524546 | ||
| Pubmed | Molecular basis for the different activation kinetics of the pacemaker channels HCN2 and HCN4. | 2.73e-06 | 2 | 58 | 2 | 12813043 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 30877792 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 30621030 | ||
| Pubmed | Two pacemaker channels from human heart with profoundly different activation kinetics. | 2.73e-06 | 2 | 58 | 2 | 10228147 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 12034718 | ||
| Pubmed | HCN channelopathy in external globus pallidus neurons in models of Parkinson's disease. | 2.73e-06 | 2 | 58 | 2 | 21076425 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 19171659 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 17261842 | ||
| Pubmed | Intracellular Mg2+ is a voltage-dependent pore blocker of HCN channels. | 2.73e-06 | 2 | 58 | 2 | 18579800 | |
| Pubmed | Mode shifts in the voltage gating of the mouse and human HCN2 and HCN4 channels. | 2.73e-06 | 2 | 58 | 2 | 16777944 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 22094222 | ||
| Pubmed | Peripheral N- and C-terminal domains determine deactivation kinetics of HCN channels. | 2.73e-06 | 2 | 58 | 2 | 17548059 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 21456027 | ||
| Pubmed | Hyperpolarization-activated channels HCN1 and HCN4 mediate responses to sour stimuli. | 2.73e-06 | 2 | 58 | 2 | 11675786 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 17931874 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 18006634 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 12890777 | ||
| Pubmed | Functional comparison of HCN isoforms expressed in ventricular and HEK 293 cells. | 2.73e-06 | 2 | 58 | 2 | 12194012 | |
| Pubmed | Case-control pharmacogenetic study of HCN1/HCN2 variants and genetic generalized epilepsies. | 2.73e-06 | 2 | 58 | 2 | 29047147 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 12433951 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 15644313 | ||
| Pubmed | A leucine zipper motif essential for gating of hyperpolarization-activated channels. | 2.73e-06 | 2 | 58 | 2 | 23048023 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 15525777 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 22948144 | ||
| Pubmed | Functional heteromerization of HCN1 and HCN2 pacemaker channels. | 2.73e-06 | 2 | 58 | 2 | 11133998 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 38565808 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 29980633 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 32543742 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 11420311 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 19135060 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 22634420 | ||
| Pubmed | Processing of retinal signals in normal and HCN deficient mice. | 2.73e-06 | 2 | 58 | 2 | 22279546 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 29547997 | ||
| Pubmed | Molecular basis of the effect of potassium on heterologously expressed pacemaker (HCN) channels. | 2.73e-06 | 2 | 58 | 2 | 12562911 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 15687126 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 19570998 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 24638995 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 19574228 | ||
| Pubmed | Evolutionary emergence of N-glycosylation as a variable promoter of HCN channel surface expression. | 2.73e-06 | 2 | 58 | 2 | 20130205 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 17553794 | ||
| Pubmed | 4.18e-06 | 19 | 58 | 3 | 15691386 | ||
| Pubmed | 4.18e-06 | 19 | 58 | 3 | 15698476 | ||
| Pubmed | 4.97e-06 | 405 | 58 | 7 | 38187761 | ||
| Pubmed | 5.13e-06 | 407 | 58 | 7 | 12693553 | ||
| Pubmed | 5.73e-06 | 21 | 58 | 3 | 30270038 | ||
| Pubmed | 5.73e-06 | 21 | 58 | 3 | 30110642 | ||
| Pubmed | Systematic Analysis of the Functions of Lysine Acetylation in the Regulation of Tat Activity. | 6.63e-06 | 22 | 58 | 3 | 23826228 | |
| Pubmed | Modifications in the human T cell proteome induced by intracellular HIV-1 Tat protein expression. | 6.63e-06 | 22 | 58 | 3 | 16526095 | |
| Pubmed | TUBB1 mutations cause thyroid dysgenesis associated with abnormal platelet physiology. | 6.63e-06 | 22 | 58 | 3 | 30446499 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 12856183 | ||
| Pubmed | Targeted deletion of Kcne2 impairs HCN channel function in mouse thalamocortical circuits. | 8.19e-06 | 3 | 58 | 2 | 22880098 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 17229476 | ||
| Pubmed | Dimerization of CUL7 and PARC is not required for all CUL7 functions and mouse development. | 8.19e-06 | 3 | 58 | 2 | 15964813 | |
| Pubmed | HCN channels expressed in the inner ear are necessary for normal balance function. | 8.19e-06 | 3 | 58 | 2 | 22090507 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 16079136 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 17298945 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 28178648 | ||
| Pubmed | EP3 activation facilitates bladder excitability via HCN channels on ICCs. | 8.19e-06 | 3 | 58 | 2 | 28131828 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 15292205 | ||
| Pubmed | Role of Nesprin-2 and RanBP2 in BICD2-associated brain developmental disorders. | 8.19e-06 | 3 | 58 | 2 | 36930595 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 16875676 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 6688039 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 22662315 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 19996274 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 19471099 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 28296713 | ||
| Pubmed | A family of hyperpolarization-activated mammalian cation channels. | 8.19e-06 | 3 | 58 | 2 | 9634236 | |
| Pubmed | The transcriptional targets of mutant FOXL2 in granulosa cell tumours. | 8.19e-06 | 3 | 58 | 2 | 23029457 | |
| Pubmed | 1.24e-05 | 653 | 58 | 8 | 22586326 | ||
| Pubmed | A directed protein interaction network for investigating intracellular signal transduction. | 1.52e-05 | 1124 | 58 | 10 | 21900206 | |
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 25042871 | ||
| Pubmed | Autism-associated SHANK3 haploinsufficiency causes Ih channelopathy in human neurons. | 1.64e-05 | 4 | 58 | 2 | 26966193 | |
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 27188442 | ||
| Interaction | HCN4 interactions | 1.88e-06 | 9 | 58 | 3 | int:HCN4 | |
| Interaction | HCN2 interactions | 6.34e-06 | 13 | 58 | 3 | int:HCN2 | |
| Interaction | PLXNB3 interactions | 1.79e-05 | 18 | 58 | 3 | int:PLXNB3 | |
| Interaction | SRGAP2 interactions | 2.14e-05 | 197 | 58 | 6 | int:SRGAP2 | |
| Interaction | PRICKLE1 interactions | 2.67e-05 | 60 | 58 | 4 | int:PRICKLE1 | |
| Interaction | PRICKLE2 interactions | 3.04e-05 | 62 | 58 | 4 | int:PRICKLE2 | |
| Interaction | MTNR1B interactions | 4.32e-05 | 135 | 58 | 5 | int:MTNR1B | |
| Interaction | CAPS interactions | 4.97e-05 | 25 | 58 | 3 | int:CAPS | |
| Interaction | ANKFY1 interactions | 5.89e-05 | 236 | 58 | 6 | int:ANKFY1 | |
| Cytoband | 6p25 | 1.86e-04 | 16 | 58 | 2 | 6p25 | |
| GeneFamily | Cyclic nucleotide gated channels | 9.37e-07 | 10 | 37 | 3 | 250 | |
| GeneFamily | Tubulins | 1.99e-05 | 26 | 37 | 3 | 778 | |
| GeneFamily | Cullins | 1.13e-04 | 8 | 37 | 2 | 1032 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_top-relative-expression-ranked_1000 | BICD2 STK3 SF3B1 MAST4 SYNE2 SERPINF1 UBQLN4 SLU7 TUBB2B TESC TST | 9.57e-06 | 819 | 57 | 11 | gudmap_developingGonad_e12.5_testes_1000 |
| CoexpressionAtlas | DevelopingGonad_P2_testes_emap-30171_top-relative-expression-ranked_1000 | BICD2 STK3 SF3B1 THRA SYNE2 SERPINF1 SLU7 TUBB2B TESC TST STAR | 9.57e-06 | 819 | 57 | 11 | gudmap_developingGonad_P2_testes_1000 |
| CoexpressionAtlas | Stem Cells, SC.STSL.BM, CD117+ IL7R- CD150- CD48- AA4.1+ CD43+, Bone marrow, avg-3 | 1.63e-05 | 423 | 57 | 8 | GSM399454_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_SertoliCell_Sox9_top-relative-expression-ranked_1000 | DPY19L3 THRA SYNE2 USP32 TUBB2B MICAL3 TESC TST STAR HPS3 HDC | 1.87e-05 | 880 | 57 | 11 | gudmap_dev gonad_e13.5_M_SertoliCell_Sox9_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_testes_emap-11164_top-relative-expression-ranked_1000 | 5.46e-05 | 814 | 57 | 10 | gudmap_developingGonad_e18.5_testes_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_testes_emap-11164_top-relative-expression-ranked_200 | 8.29e-05 | 166 | 57 | 5 | gudmap_developingGonad_e18.5_testes_200 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_top-relative-expression-ranked_500 | 1.03e-04 | 406 | 57 | 7 | gudmap_developingGonad_e12.5_testes_500 | |
| ToppCell | P07-Epithelial-alveolar_epithelial_cell-type_II_pneumocyte|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.96e-08 | 166 | 58 | 6 | 021b9344de7957762f81b09a647504b8c8289cf1 | |
| ToppCell | P07-Epithelial-epithelial_progenitor_cell-epi_progenitor|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.85e-08 | 169 | 58 | 6 | 1a47a4892a5e6a69555f5332308503526e5422a7 | |
| ToppCell | P07-Epithelial-epithelial_progenitor_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.75e-06 | 169 | 58 | 5 | ec23caecbb0d969307e33e9df8499ddcd1420305 | |
| ToppCell | P07-Epithelial-epithelial_progenitor_cell-epithelial_progenitor_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.75e-06 | 169 | 58 | 5 | 53e863de064d44e1d36e21fb3dbba37ae020f6e9 | |
| ToppCell | P15-Epithelial-alveolar_epithelial_cell-type_II_pneumocyte|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.83e-06 | 170 | 58 | 5 | 6c0619cbe2f01a6de18da0a137f92bda0cbdf075 | |
| ToppCell | P03-Epithelial-alveolar_epithelial_cell-type_II_pneumocyte|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.83e-06 | 170 | 58 | 5 | 3fd37e9b377d6485cea1262c31a8507d18a78514 | |
| ToppCell | P07-Epithelial|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.08e-06 | 173 | 58 | 5 | 8b10087a917b825809d35a2b2b349c73a2782472 | |
| ToppCell | P28-Epithelial-alveolar_epithelial_cell-type_II_pneumocyte|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.26e-06 | 175 | 58 | 5 | 8a4ed775ff973123dbcfe9c809959d11a62450c9 | |
| ToppCell | Control-Myeloid-ncMonocyte|World / Disease state, Lineage and Cell class | 5.52e-06 | 195 | 58 | 5 | b4444b67a709e82b8e2ee510924c3152cb88b051 | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 6.10e-06 | 199 | 58 | 5 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Smooth_muscle-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 6.25e-06 | 200 | 58 | 5 | 0c648941447c738caf62f2d71e296d6cca492c8b | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.25e-06 | 200 | 58 | 5 | 522a51a284d2992d519c4669e1a48c8ebcc08c80 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.25e-06 | 200 | 58 | 5 | 94f1fa61aa82eb9f411b2b1cb759476939ab5db7 | |
| ToppCell | droplet-Heart-HEART-1m-Hematologic-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-05 | 127 | 58 | 4 | 983489a69d3b1f1fe21110a862ac1dba53e9d31c | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 3.16e-05 | 138 | 58 | 4 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | facs-Lung-EPCAM-3m-Hematologic-leukocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.34e-05 | 140 | 58 | 4 | 731b46e4b815a45af1d0ce7ab4d0d0324ac8798f | |
| ToppCell | facs-Lung-EPCAM-3m-Hematologic-Proliferating_Immune|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.34e-05 | 140 | 58 | 4 | b30fc389583406ee6cb55112d0f7250d1b74c88a | |
| ToppCell | facs-Lung-EPCAM-3m-Hematologic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.34e-05 | 140 | 58 | 4 | 35ecd887bb7827603ef673912ba820208a6368d2 | |
| ToppCell | COVID-19_Severe-MAIT|COVID-19_Severe / disease group, cell group and cell class | 4.38e-05 | 150 | 58 | 4 | 923ea7ecc0aa05fb0396082cd9c3d1594135f1e0 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-T_lymphocytic-T_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.38e-05 | 150 | 58 | 4 | c922dbb4c9c12ccf08bd5f6168b20606c605d052 | |
| ToppCell | Influenza_Severe-CD4+_CTL|World / Disease group and Cell class | 4.73e-05 | 153 | 58 | 4 | 0c6c2c6dbc81badd886f125f4e5ba0fb7d52101c | |
| ToppCell | TCGA-Mesothelium-Primary_Tumor-Mesothelioma-Epitheliod-2|TCGA-Mesothelium / Sample_Type by Project: Shred V9 | 5.63e-05 | 160 | 58 | 4 | d288b0a315f6adc0be4bdc89fa67bf93679a743f | |
| ToppCell | Adult-Immune-mast_cell|Adult / Lineage, Cell type, age group and donor | 5.77e-05 | 161 | 58 | 4 | 44f5c0256b3ce264a6c7b62740f32dcd45ee052d | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-neutrophil|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.91e-05 | 162 | 58 | 4 | 9c9a63adb692651ea5a52cc77b02c5ce11d0ccea | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-neutrophil-neutrophil|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.91e-05 | 162 | 58 | 4 | 1d29983b22f963b34e72cfd1eec328d2d7c4932f | |
| ToppCell | Influenza_Severe-CD4+_CTL|Influenza_Severe / Disease group and Cell class | 6.19e-05 | 164 | 58 | 4 | 9ffd40ae1f39290840bea79fa4e73cb7e009f310 | |
| ToppCell | 11.5-Airway-RBC-RBC|Airway / Age, Tissue, Lineage and Cell class | 6.34e-05 | 165 | 58 | 4 | 8618b2c5659aa70c7c9d6e51a227ac612b4ad17b | |
| ToppCell | 11.5-Airway-RBC|Airway / Age, Tissue, Lineage and Cell class | 6.34e-05 | 165 | 58 | 4 | 46042340a373adaf1c439b2301e02fbae3e31a4f | |
| ToppCell | severe_influenza-CD4+_CTL|World / disease group, cell group and cell class (v2) | 6.49e-05 | 166 | 58 | 4 | cdc3e200373718f26fe02ee516928097103f46e2 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Myeloid-cDC2|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.64e-05 | 167 | 58 | 4 | 1bd0aa7a3c8649f342bb856cf861c4c5984ad889 | |
| ToppCell | COVID-19_Severe-CD4+_CTL|World / disease group, cell group and cell class | 6.96e-05 | 169 | 58 | 4 | 8c8168ac93a808d7b4756e4491db2b2979df1c1f | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_neutrophil-granulo-neutrophil-promyelocyte|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.96e-05 | 169 | 58 | 4 | f33f4a0baad1b3cb5be61dfc7b00c7a3845f7120 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.45e-05 | 172 | 58 | 4 | e15ab284df6dd241d4481f98864b18c39d757b8c | |
| ToppCell | E18.5-samps-Epithelial-Alveolar_epithelial-AT2|E18.5-samps / Age Group, Lineage, Cell class and subclass | 7.62e-05 | 173 | 58 | 4 | f6e36ea98a9c669ff393d141455aaecef083f738 | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.79e-05 | 174 | 58 | 4 | 9d5dcd46cf346c381dea68ada6665f7fb68114a3 | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.79e-05 | 174 | 58 | 4 | 53cec5c666c45278a71c21dd9c62a052a97e0fdf | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-Megakaryocyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.96e-05 | 175 | 58 | 4 | b85279b9efd72d7074c4226d50ce139a38c0e1c1 | |
| ToppCell | 10x5'-blood-Lymphocytic_Invariant-Inducer-like-MAIT|blood / Manually curated celltypes from each tissue | 7.96e-05 | 175 | 58 | 4 | b4e4b66e89f79999768a6192c8404cb2465f920b | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-neurons_A|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.14e-05 | 176 | 58 | 4 | 116741fef5895ca85057d2d31eca9eba5764ab44 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-neurons_A-Branch_A1_(iMN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.14e-05 | 176 | 58 | 4 | 5b707f58d164ee7a6a527dd5d053472ce9a631c1 | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Mac-Intestinal_macrophages|lymph-node_spleen / Manually curated celltypes from each tissue | 8.32e-05 | 177 | 58 | 4 | 52c2ba74a8605260a2623e7d151286e504ac4d19 | |
| ToppCell | Endothelial-Endothelial-C|Endothelial / shred on cell class and cell subclass (v4) | 8.32e-05 | 177 | 58 | 4 | b5b9278dfd76b1aacd88e5fe86e91a2c9b565f87 | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Endothelial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.51e-05 | 178 | 58 | 4 | f2002a5c4758d0af6c1880ca12f0af0d5e8888e4 | |
| ToppCell | droplet-Fat-SCAT-30m-Mesenchymal-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.51e-05 | 178 | 58 | 4 | 5cf12927f0756c4d8a289fe4308d736382e6212e | |
| ToppCell | TCGA-Adrenal-Primary_Tumor-Pheochromocytoma-Pheochromocytoma-1|TCGA-Adrenal / Sample_Type by Project: Shred V9 | 8.69e-05 | 179 | 58 | 4 | 431e1b29015ec817f778499106d24b19cfc825ae | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.88e-05 | 180 | 58 | 4 | c4068fe47408cfd899131a85fa4b7e5908926f94 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-CD8+_T-MAIT-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.88e-05 | 180 | 58 | 4 | 163c34783f013b3904ae2d43b7edde4d55a3e2e5 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-CD8+_T-MAIT|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.88e-05 | 180 | 58 | 4 | 12cd0b1c8cdf4b11f057657e2196c20ed54d222a | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-neurons_A-Branch_A4_(IN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.07e-05 | 181 | 58 | 4 | fb4df9a128761abe5c6310a30d7b2f7f2fdef46d | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.27e-05 | 182 | 58 | 4 | 205d9ad1ea4b7adee8054496cdde46c9c401a19a | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.47e-05 | 183 | 58 | 4 | 01ad18f198195ce341bae01a1c8c253cc4607766 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Epithelial-Bergmann_glial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.47e-05 | 183 | 58 | 4 | 99bb4ceb92f6467f2359a42ab2cff6df18825a30 | |
| ToppCell | facs-Thymus|facs / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.67e-05 | 184 | 58 | 4 | 58beef66bbbde2479ec69dfef392d5941cedf230 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-hematologic|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 9.87e-05 | 185 | 58 | 4 | 9f1a790680caaf9c1ec35db5e4b7641497401179 | |
| ToppCell | systemic_lupus_erythematosus-flare-Myeloid-plasmacytoid_dendritic_cell-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.03e-04 | 187 | 58 | 4 | d3563bb087e476baea5b59389e4d34d0ff98cac5 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-Myeloid-MMP9+_Inflammatory_macrophage|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.05e-04 | 188 | 58 | 4 | fcf1bebef7aa81b4a11c1f9e4319339c290ecd22 | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 188 | 58 | 4 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_A-Branch_A3_(IPAN/IN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.05e-04 | 188 | 58 | 4 | bd091503f580dedab40e0996273101285d24b586 | |
| ToppCell | CF-Lymphoid-T_cell_&_NK_cell|Lymphoid / Disease state, Lineage and Cell class | 1.05e-04 | 188 | 58 | 4 | 15057036b46c9df621ec4955aa94ca3036245d45 | |
| ToppCell | COPD-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 1.05e-04 | 188 | 58 | 4 | 186fe1ea328c942910190a4240262c0d8642ea3b | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-Trm_Th1/Th17|Lung / Manually curated celltypes from each tissue | 1.07e-04 | 189 | 58 | 4 | f43960506ed3e699e910ec7711c1113e2e9b80d1 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.09e-04 | 190 | 58 | 4 | 55df73c8b696967a925b1772631f6900eff0fa30 | |
| ToppCell | Control-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 1.09e-04 | 190 | 58 | 4 | 7f3f419fffe02934b6f27b697f7a6401072491ed | |
| ToppCell | COPD-Myeloid-Mast|Myeloid / Disease state, Lineage and Cell class | 1.09e-04 | 190 | 58 | 4 | 379dbac19110b76079a7a53209569e060a852acb | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.09e-04 | 190 | 58 | 4 | 494fbab37305a7f92cddec75b291d42282555f5f | |
| ToppCell | CTRL-Lymphoid-T_cell_&_NK_cell|Lymphoid / Disease state, Lineage and Cell class | 1.12e-04 | 191 | 58 | 4 | 32381d353e40bce77a5b63c7bdbe360d27327d86 | |
| ToppCell | ASK454-Epithelial-Secretory|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.12e-04 | 191 | 58 | 4 | c63c781e7e93265e591cf494cb4ce8ed797c24fb | |
| ToppCell | Endothelial-C|World / shred on cell class and cell subclass (v4) | 1.12e-04 | 191 | 58 | 4 | bf203931f973098b79ec681d1dd0854419819e98 | |
| ToppCell | (210)_NKT_cell|World / immune cells in Peripheral Blood (logTPM normalization) | 1.14e-04 | 192 | 58 | 4 | 08dc0c019c594da7b9944db8fd706aa7780e6ae9 | |
| ToppCell | COPD-Lymphoid-T|World / Disease state, Lineage and Cell class | 1.14e-04 | 192 | 58 | 4 | eb4909574fb5fc91399463523e2737095773200a | |
| ToppCell | Healthy_Control-Lymphoid-T-CD8_T|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 1.14e-04 | 192 | 58 | 4 | 36b6ea21b0b1342f2dcac4dcaf359b6c772203f7 | |
| ToppCell | (21)_NKT_cell|World / immune cells in Peripheral Blood (logTPM normalization) | 1.14e-04 | 192 | 58 | 4 | b0a573ddde2978485a857b8261ee1ee5ef68ecef | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Mesenchymal_3|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.14e-04 | 192 | 58 | 4 | d88753b200d9c8da6716222d697ddf0a1548d6c8 | |
| ToppCell | facs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-04 | 192 | 58 | 4 | 1ccc47792edf9ee23501c8e2165d11271636b66a | |
| ToppCell | IPF-Stromal-Pericyte|Stromal / Disease state, Lineage and Cell class | 1.19e-04 | 194 | 58 | 4 | 3892b188f424ffb80f3c75a1b6709a21c1e1601d | |
| ToppCell | Control-Myeloid-ncMonocyte|Control / Disease state, Lineage and Cell class | 1.21e-04 | 195 | 58 | 4 | fcb05948e7480dc53f06f3fc9b9c3fc129874edd | |
| ToppCell | Control-Lymphoid-T|Lymphoid / Disease state, Lineage and Cell class | 1.21e-04 | 195 | 58 | 4 | 6687e579582d7a239bee80846de0cf827a6f6a62 | |
| ToppCell | CV-Moderate-6|Moderate / Virus stimulation, Condition and Cluster | 1.21e-04 | 195 | 58 | 4 | 2b8a72d7e755b9655c7a496000d10ff06e50862b | |
| ToppCell | COPD-Lymphoid-T|COPD / Disease state, Lineage and Cell class | 1.23e-04 | 196 | 58 | 4 | 30e53b8050d2a041f855d0e39bbd8f923c64c489 | |
| ToppCell | 10x5'-GI_small-bowel-Myeloid_Mac-Intestinal_macrophages|GI_small-bowel / Manually curated celltypes from each tissue | 1.23e-04 | 196 | 58 | 4 | 075e5746fa5cb121115a1d51b823c0fbf8d54305 | |
| ToppCell | CV-Moderate-6|CV / Virus stimulation, Condition and Cluster | 1.23e-04 | 196 | 58 | 4 | 7bced0cc2112697593c478fa291b8ed3941fb811 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-PFC|World / Primary Cells by Cluster | 1.26e-04 | 197 | 58 | 4 | 2c3b0072f8e1e09c77a85c6fc3133d1796932fb2 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.26e-04 | 197 | 58 | 4 | 8af4a1e35ce9fb4ea3d26ab619599efb7eac43a5 | |
| ToppCell | normal-na-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-female|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.26e-04 | 197 | 58 | 4 | b5b333e98753946793ceb45e2d85c25ef53568b4 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_A-Branch_A1_(iMN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.26e-04 | 197 | 58 | 4 | fd43fc1cbf0c17b370397d73dddc572565a759c7 | |
| ToppCell | normal-na-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.26e-04 | 197 | 58 | 4 | 4cec48e202f4583c9328d4b722c49ed3471ec173 | |
| ToppCell | Influenza-Influenza_Severe-Lymphocyte-T/NK-CD4+_CTL|Influenza_Severe / Disease, condition lineage and cell class | 1.26e-04 | 197 | 58 | 4 | 8610307434d99e6411a5a6c6769094e9a0749d4d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.26e-04 | 197 | 58 | 4 | 32b770e403028862f91e4727f4a8fbb6151910e4 | |
| ToppCell | 5'-Adult-Appendix-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.26e-04 | 197 | 58 | 4 | e8e879b7634a29569061d3515d180784094a31e7 | |
| ToppCell | Monocytes-NUPR1+_Monocytes|Monocytes / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.26e-04 | 197 | 58 | 4 | 8a058c9d9285acd7cf2fb8e34f7602a86b5d6c89 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-PFC-29|World / Primary Cells by Cluster | 1.26e-04 | 197 | 58 | 4 | c5bc0e7eb85642b270efc2ba92b13a736af22052 | |
| ToppCell | COVID-CD4-exh_CD4|COVID / Condition, Cell_class and T cell subcluster | 1.26e-04 | 197 | 58 | 4 | 39ee4b93625c994813044d8dd8854fba2bd99940 | |
| ToppCell | Healthy_Control-Lymphoid|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 1.28e-04 | 198 | 58 | 4 | c176c583f426e4373daca4a696ab8832e838cfbf | |
| ToppCell | Control-Lymphoid|Control / Condition, Lineage and Cell class | 1.28e-04 | 198 | 58 | 4 | 5aa3ce2eaed62f341abf47895d651aec5e14e729 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-CD8+_T-CD8+_T-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.28e-04 | 198 | 58 | 4 | 06b1f14d428d816dc471c21faa91993f8fb701e2 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-CD8+_T-CD8+_T|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.28e-04 | 198 | 58 | 4 | 2977e16a8dc92d69b6ed184316136f7f740fb4fd | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.28e-04 | 198 | 58 | 4 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-CD8+_T|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.28e-04 | 198 | 58 | 4 | b718abbd7c2706866d191fb54f27ce5f594c34a6 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 1.28e-04 | 198 | 58 | 4 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | VE-CD8-CD8_1|VE / Condition, Cell_class and T cell subcluster | 1.28e-04 | 198 | 58 | 4 | 9747a486fddec917a3753651de0b2079ac2385ee | |
| Drug | vinorelbine base | 1.87e-06 | 80 | 58 | 5 | CID000005672 | |
| Drug | NSC91998 | 1.99e-06 | 81 | 58 | 5 | CID000005668 | |
| Drug | GaCl3 | 8.00e-06 | 50 | 58 | 4 | CID000026010 | |
| Drug | combretastatin | 8.66e-06 | 51 | 58 | 4 | CID000100154 | |
| Drug | zatebradine | 1.04e-05 | 17 | 58 | 3 | CID000065637 | |
| Drug | Homatropine hydrobromide (R,S) [51-56-9]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 1.05e-05 | 196 | 58 | 6 | 1684_DN | |
| Drug | estradiol, USP; Down 200; 0.01uM; PC3; HT_HG-U133A | 1.05e-05 | 196 | 58 | 6 | 4465_DN | |
| Drug | Etofenamate [30544-47-9]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 1.11e-05 | 198 | 58 | 6 | 7327_UP | |
| Drug | Phentolamine hydrochloride [73-05-2]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 1.15e-05 | 199 | 58 | 6 | 3860_DN | |
| Drug | AH6809; Down 200; 1uM; PC3; HT_HG-U133A | 1.15e-05 | 199 | 58 | 6 | 7075_DN | |
| Drug | tribromodiphenyl ether 28 | 1.25e-05 | 18 | 58 | 3 | ctd:C533760 | |
| Drug | AC1L8WWP | 1.26e-05 | 56 | 58 | 4 | CID000388944 | |
| Drug | HCNs | 1.73e-05 | 20 | 58 | 3 | CID006857665 | |
| Drug | benomyl | 1.87e-05 | 128 | 58 | 5 | CID000028780 | |
| Drug | zatebradine | 1.91e-05 | 3 | 58 | 2 | ctd:C043636 | |
| Drug | PIPES | 2.15e-05 | 64 | 58 | 4 | CID000079723 | |
| Drug | AAGTP | 2.15e-05 | 64 | 58 | 4 | CID000656407 | |
| Drug | IKP104 | 2.68e-05 | 23 | 58 | 3 | CID000130739 | |
| Drug | 2,3,4-TCB | 2.68e-05 | 23 | 58 | 3 | CID000129239 | |
| Drug | AC1L2P05 | 2.68e-05 | 23 | 58 | 3 | CID000125688 | |
| Drug | 2,3,4-tabp | 2.68e-05 | 23 | 58 | 3 | CID000125548 | |
| Drug | N-acetylcolchinol | 2.68e-05 | 23 | 58 | 3 | CID000097865 | |
| Drug | NSC355636 | 2.68e-05 | 23 | 58 | 3 | CID000100176 | |
| Drug | vindesine | 2.73e-05 | 68 | 58 | 4 | CID000040839 | |
| Drug | parbendazole | 3.06e-05 | 24 | 58 | 3 | CID000026596 | |
| Drug | NSC-36768 | 3.06e-05 | 24 | 58 | 3 | CID000165441 | |
| Drug | deacetamidocolchicine | 3.06e-05 | 24 | 58 | 3 | CID000014995 | |
| Drug | tropolone methyl ether | 3.06e-05 | 24 | 58 | 3 | CID000016546 | |
| Drug | colchicide | 3.06e-05 | 24 | 58 | 3 | CID000120712 | |
| Drug | AC1L4TG7 | 3.06e-05 | 24 | 58 | 3 | CID000163705 | |
| Drug | NBD-colcemid | 3.47e-05 | 25 | 58 | 3 | CID000130594 | |
| Drug | AC1Q6P06 | 3.47e-05 | 25 | 58 | 3 | CID000160263 | |
| Drug | 2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone | 3.47e-05 | 25 | 58 | 3 | CID000043264 | |
| Drug | allocolchicine | 3.47e-05 | 25 | 58 | 3 | CID000196989 | |
| Drug | 55623-37-5 | 3.47e-05 | 25 | 58 | 3 | CID006438440 | |
| Drug | 10-deacetylbaccatin III | 3.47e-05 | 25 | 58 | 3 | CID000125001 | |
| Drug | MDL 27048 | 3.47e-05 | 25 | 58 | 3 | CID006439188 | |
| Drug | 7B-forskolin | 3.91e-05 | 26 | 58 | 3 | CID000130638 | |
| Drug | NSC527981 | 3.91e-05 | 26 | 58 | 3 | CID000352796 | |
| Drug | NSC332029 | 3.91e-05 | 26 | 58 | 3 | CID000100073 | |
| Drug | pironetin | 3.91e-05 | 26 | 58 | 3 | CID006438891 | |
| Drug | AC1L1J4H | 4.39e-05 | 27 | 58 | 3 | CID000004862 | |
| Drug | NSC292222 | 4.39e-05 | 27 | 58 | 3 | CID000099957 | |
| Drug | dinitroanilines | 4.39e-05 | 27 | 58 | 3 | CID000136400 | |
| Drug | NSC D-669356 | 4.39e-05 | 27 | 58 | 3 | CID000178028 | |
| Drug | NSC 370147 | 4.91e-05 | 28 | 58 | 3 | CID000182762 | |
| Drug | NSC72302 | 4.91e-05 | 28 | 58 | 3 | CID000118078 | |
| Drug | bis-ANS | 5.45e-05 | 81 | 58 | 4 | CID000123808 | |
| Drug | oxibendazole | 5.47e-05 | 29 | 58 | 3 | CID000004622 | |
| Drug | AC1NBBHE | 6.07e-05 | 30 | 58 | 3 | CID004490620 | |
| Drug | eleutherobin | 6.07e-05 | 30 | 58 | 3 | CID006918335 | |
| Drug | azatoxin | 6.07e-05 | 30 | 58 | 3 | CID000125383 | |
| Drug | NSC617668 | 6.07e-05 | 30 | 58 | 3 | CID000357989 | |
| Drug | citostal | 6.07e-05 | 30 | 58 | 3 | CID000018991 | |
| Drug | thiocolchicine | 6.07e-05 | 30 | 58 | 3 | CID000017648 | |
| Drug | 4-pyridinecarboxaldehyde | 6.35e-05 | 5 | 58 | 2 | CID000013389 | |
| Drug | 2,3,7,8-tetrabromodibenzofuran | 6.35e-05 | 5 | 58 | 2 | CID000049973 | |
| Drug | tropone | 6.70e-05 | 31 | 58 | 3 | CID000010881 | |
| Drug | NSC609395 | 6.70e-05 | 31 | 58 | 3 | CID005488798 | |
| Drug | amiprophosmethyl | 6.70e-05 | 31 | 58 | 3 | CID000100524 | |
| Drug | 3,4-dimethylhexane-2,5-dione | 6.70e-05 | 31 | 58 | 3 | CID000032851 | |
| Drug | AC1L3V8I | 6.70e-05 | 31 | 58 | 3 | CID000122777 | |
| Drug | NSC332598 | 6.70e-05 | 31 | 58 | 3 | CID000615942 | |
| Drug | N,N'-ethylenebis(iodoacetamide | 6.70e-05 | 31 | 58 | 3 | CID000023678 | |
| Drug | AC1L1G95 | 7.38e-05 | 32 | 58 | 3 | CID000003583 | |
| Drug | NSC153858 | 7.38e-05 | 32 | 58 | 3 | CID000547450 | |
| Drug | 2-demethylcolchicine | 7.38e-05 | 32 | 58 | 3 | CID000023757 | |
| Drug | CA4P | 8.11e-05 | 33 | 58 | 3 | CID000370232 | |
| Drug | taltobulin | 8.11e-05 | 33 | 58 | 3 | CID006918637 | |
| Drug | mebendazole | 8.11e-05 | 33 | 58 | 3 | CID000004030 | |
| Drug | NSC376450 | 8.88e-05 | 34 | 58 | 3 | CID000005605 | |
| Drug | 2-phenyl-4-quinolone | 8.88e-05 | 34 | 58 | 3 | CID000161091 | |
| Drug | Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A | 9.05e-05 | 178 | 58 | 5 | 3998_DN | |
| Drug | Captopril [62571-86-2]; Down 200; 17.2uM; PC3; HT_HG-U133A | 9.29e-05 | 179 | 58 | 5 | 4585_DN | |
| Drug | benzimidazole | 9.35e-05 | 93 | 58 | 4 | CID000005798 | |
| Drug | Rp-8-CPT-cAMPS | 9.69e-05 | 35 | 58 | 3 | CID010413188 | |
| Drug | discodermolide | 9.69e-05 | 35 | 58 | 3 | CID000643668 | |
| Drug | AC1O5Y0F | 1.15e-04 | 37 | 58 | 3 | CID006442852 | |
| Drug | DTAF | 1.15e-04 | 37 | 58 | 3 | CID000123934 | |
| Drug | albendazole | 1.15e-04 | 37 | 58 | 3 | CID000002082 | |
| Drug | baccatin III | 1.15e-04 | 37 | 58 | 3 | CID000065366 | |
| Drug | Securinine [5610-40-2]; Up 200; 18.4uM; HL60; HT_HG-U133A | 1.20e-04 | 189 | 58 | 5 | 2729_UP | |
| Drug | AC1L1IZ2 | 1.22e-04 | 304 | 58 | 6 | CID000004795 | |
| Drug | laulimalide | 1.24e-04 | 38 | 58 | 3 | CID006918457 | |
| Drug | gnoscopine | 1.24e-04 | 38 | 58 | 3 | CID000004544 | |
| Drug | colchiceine | 1.24e-04 | 38 | 58 | 3 | CID000010156 | |
| Drug | NDHSA | 1.33e-04 | 7 | 58 | 2 | CID000115174 | |
| Drug | 2-bromophenol | 1.33e-04 | 7 | 58 | 2 | ctd:C032038 | |
| Drug | Dicamba | 1.33e-04 | 7 | 58 | 2 | ctd:D003996 | |
| Drug | 2,4,6-trichlorophenol | 1.33e-04 | 7 | 58 | 2 | ctd:C024564 | |
| Drug | ivabradine | 1.34e-04 | 39 | 58 | 3 | CID000132999 | |
| Drug | erianin | 1.34e-04 | 39 | 58 | 3 | CID000356759 | |
| Drug | Dolastatin 10 | 1.34e-04 | 39 | 58 | 3 | CID000100208 | |
| Drug | LY 294002; Up 200; 10uM; PC3; HT_HG-U133A | 1.36e-04 | 194 | 58 | 5 | 1239_UP | |
| Drug | Pentoxifylline [6493-05-6]; Down 200; 14.4uM; MCF7; HT_HG-U133A | 1.36e-04 | 194 | 58 | 5 | 6021_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 1000uM; PC3; HT_HG-U133A | 1.39e-04 | 195 | 58 | 5 | 4433_DN | |
| Drug | Taxane | 1.39e-04 | 103 | 58 | 4 | CID000108169 | |
| Drug | Piperacillin sodium salt [59703-84-3]; Up 200; 7.4uM; PC3; HT_HG-U133A | 1.42e-04 | 196 | 58 | 5 | 3763_UP | |
| Drug | Pizotifen malate [5189-11-7]; Down 200; 9.4uM; PC3; HT_HG-U133A | 1.42e-04 | 196 | 58 | 5 | 5072_DN | |
| Drug | etiracetam | 1.45e-04 | 40 | 58 | 3 | ctd:C026098 | |
| Disease | facial paralysis (implicated_via_orthology) | 8.56e-07 | 10 | 58 | 3 | DOID:13934 (implicated_via_orthology) | |
| Disease | complex cortical dysplasia with other brain malformations 7 (implicated_via_orthology) | 8.56e-07 | 10 | 58 | 3 | DOID:0090132 (implicated_via_orthology) | |
| Disease | ptosis (implicated_via_orthology) | 8.56e-07 | 10 | 58 | 3 | DOID:0060260 (implicated_via_orthology) | |
| Disease | tubulinopathy (implicated_via_orthology) | 8.56e-07 | 10 | 58 | 3 | DOID:0112227 (implicated_via_orthology) | |
| Disease | cerebellar ataxia, mental retardation and dysequlibrium syndrome (implicated_via_orthology) | 1.57e-06 | 12 | 58 | 3 | DOID:0050997 (implicated_via_orthology) | |
| Disease | meningitis (biomarker_via_orthology) | 3.80e-06 | 2 | 58 | 2 | DOID:9471 (biomarker_via_orthology) | |
| Disease | sick sinus syndrome (implicated_via_orthology) | 1.14e-05 | 3 | 58 | 2 | DOID:13884 (implicated_via_orthology) | |
| Disease | response to non-steroidal anti-inflammatory, drug-induced liver injury | 2.27e-05 | 4 | 58 | 2 | EFO_0004228, EFO_0005533 | |
| Disease | PR interval | 5.15e-05 | 495 | 58 | 7 | EFO_0004462 | |
| Disease | Gilles de la Tourette syndrome (is_implicated_in) | 5.67e-05 | 6 | 58 | 2 | DOID:11119 (is_implicated_in) | |
| Disease | waist-hip ratio | 1.25e-04 | 1226 | 58 | 10 | EFO_0004343 | |
| Disease | Autistic Disorder | 1.63e-04 | 261 | 58 | 5 | C0004352 | |
| Disease | delta-6 desaturase measurement | 3.92e-04 | 15 | 58 | 2 | EFO_0007765 | |
| Disease | Diabetic Angiopathies | 4.48e-04 | 16 | 58 | 2 | C0011875 | |
| Disease | Microangiopathy, Diabetic | 4.48e-04 | 16 | 58 | 2 | C0025945 | |
| Disease | endometriosis (biomarker_via_orthology) | 4.48e-04 | 16 | 58 | 2 | DOID:289 (biomarker_via_orthology) | |
| Disease | feeling "fed-up" measurement | 4.58e-04 | 76 | 58 | 3 | EFO_0009588 | |
| Disease | depressive symptom measurement, response to antidepressant | 7.02e-04 | 88 | 58 | 3 | EFO_0007006, GO_0036276 | |
| Disease | polycystic ovary syndrome (biomarker_via_orthology) | 7.78e-04 | 21 | 58 | 2 | DOID:11612 (biomarker_via_orthology) | |
| Disease | reticulocyte measurement | 1.01e-03 | 1053 | 58 | 8 | EFO_0010700 | |
| Disease | Prostatic Neoplasms | 1.30e-03 | 616 | 58 | 6 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 1.30e-03 | 616 | 58 | 6 | C0376358 | |
| Disease | endometrial carcinoma | 1.45e-03 | 113 | 58 | 3 | EFO_1001512 | |
| Disease | amyotrophic lateral sclerosis (is_marker_for) | 1.49e-03 | 29 | 58 | 2 | DOID:332 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MSAPSEEEEYARLVM | 1 | Q8TD16 | |
| PGMMDELSELREFYD | 541 | Q6ZPD9 | |
| MRPEVYRLINEEAMV | 296 | Q9P1Z9 | |
| FLSSFRVPYEEIRMM | 726 | Q9NSV4 | |
| RVPYEEIRMMILEVD | 731 | Q9NSV4 | |
| PMDLATMEERVQRRY | 2971 | Q12830 | |
| SVYRPADGDMRMVIV | 246 | Q8TAM1 | |
| DAVERTMMYDGIRLP | 196 | Q15311 | |
| TMMYDGIRLPAVFRE | 201 | Q15311 | |
| PRDRMLMFEELSDIF | 351 | Q9NZL6 | |
| MMEPEEYRERGREMV | 1 | P19113 | |
| AMVRYESELMIFARE | 1906 | Q7RTP6 | |
| DFRNYMMRDETLEPL | 281 | Q5TCQ9 | |
| EMEYTEGISQRMRVP | 36 | Q9GZY8 | |
| RYQRSLPGESEEMME | 51 | P19823 | |
| PFETDMLTLTRYVME | 6 | O00757 | |
| MRVRMLDDYEEISAG | 381 | Q14999 | |
| EVLEEYPMMRRAFET | 691 | Q9Y3Q4 | |
| YPMMRRAFETVALDR | 696 | Q9Y3Q4 | |
| YRRMLMEDFSLSPEI | 426 | Q92896 | |
| EVLEEYPMMRRAFET | 571 | O60741 | |
| YPMMRRAFETVAIDR | 576 | O60741 | |
| MPGEMRNDLYITIER | 396 | Q8N1I0 | |
| YESMRYQPVVDLVMR | 361 | P11511 | |
| MTMAPDVRLEYLEEV | 1 | Q9UFH2 | |
| RVTADGRMEYLLVME | 266 | Q13873 | |
| LSMRFMDPEMETRYS | 611 | O60266 | |
| PVDMARMYFAETVLA | 666 | O15021 | |
| GMRVRMLDDYEEISA | 386 | Q8IWT3 | |
| DNFNEVLEEYPMMRR | 636 | Q9UL51 | |
| VLEEYPMMRRAFETV | 641 | Q9UL51 | |
| LMREMYDRAAEVPSS | 811 | Q12756 | |
| YMDELSFLSPMEMER | 376 | Q5VWQ0 | |
| TMVYDGFRPEDLMEA | 846 | Q9HCH5 | |
| ERIRPMVRDGVYFMY | 226 | Q8N142 | |
| YAEMVPVLRMVEGDT | 211 | Q9BUR4 | |
| SVEEMLEMPRLYRED | 4546 | Q8WXH0 | |
| FRDQMYIIEMPLSEA | 121 | Q969F9 | |
| REEYPDRIMNSFSVM | 156 | Q9H4B7 | |
| REEYPDRIMNTFSVM | 156 | Q13885 | |
| MVFMPDEDERKEYIL | 146 | P49221 | |
| DRLPEDMARFYLAEM | 171 | Q5VT25 | |
| IMSYFRPIDTTMDEE | 91 | Q96BS2 | |
| EIFEESYRQVMKMRP | 401 | Q9HAU4 | |
| LVEEITEEQYYMMRR | 531 | Q8N1K5 | |
| YLGRRMFIVISEPDM | 81 | P24557 | |
| DPMMEREIEELRQRY | 456 | Q13188 | |
| PDTVTAREMERLEMY | 151 | Q9NUR3 | |
| FYLDEERTVRVPMMS | 231 | P36955 | |
| ERLYEELVERMEAMG | 131 | P49675 | |
| STMRPDIDNMDEYVR | 611 | O75533 | |
| LDPEVFKEMMRFIYT | 246 | Q6IQ16 | |
| REEYPDRIMNTFSVM | 156 | Q9BVA1 | |
| DEIYEDLMRSEPVSM | 171 | P15498 | |
| PPKMRRVAETDYEME | 2566 | P21359 | |
| PTEEEMEAYRMKRQR | 561 | O95391 | |
| MDRDVDRISRPMDMY | 1286 | P49750 | |
| DRISRPMDMYDRSLD | 1291 | P49750 | |
| MEIMSLRAAVRYDPE | 256 | P10827 | |
| IEECRDTASPYEMML | 61 | Q16762 | |
| ALRRMYTDIQEPMFS | 281 | Q9NRR5 | |
| ESGNYVIREEMERML | 106 | Q8NFA0 | |
| MTQEPFREELAYDRM | 1 | Q15049 | |
| DEMDRMVYRVLVQSP | 561 | Q9NR99 |